Logo

Texas Researchers to Use Bioserve Bank to Link Genes to Thoracic Aortic Disease

Jun 19, 2007
NEW YORK (GenomeWeb News) — The Specialized Clinical Center of Research in Houston will use Bioserve’s Global Repository to study genetic links to thoracic aortic disease, Bioserve said today.
 
Bioserve said it will provide the SCCOR with access to “certain unique sample sets” from the company’s repository, which includes 600,000 DNA, tissue, and serum samples along with clinical and demographic data.  
 
The SCCOR program is a collaborative effort of the University of Texas Health Science Center Houston, Baylor College of Medicine, and the University of Texas Medical Branch.
 
The company said the SCCOR will use the samples to look for genes that can predict the development and progression of thoracic aortic diseases.
 
The SCCOR study is funded by a five-year grant from the National Heart, Lung and Blood Institute.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.